Key result
Increasing the length of a poly(ethylene glycol) spacer in bis(trimethylammonium) compounds decreased both association and dissociation rate constants for acetylcholine receptor blockade.
The blockade kinetics of open-channel blockers for the AChR can be tuned by modifying the length of a PEG spacer, providing insights for future drug design.
Preclinical findings only; leaves open whether PEG spacer length affects clinical acetylcholine receptor blockade efficacy or selectivity.
Blocking open ion channels provides a promising way to modulate synaptic transmission. Using the muscle-type acetylcholine receptor (AChR) as a test system, we seek to develop blockers that have blockade kinetics tunable via structural modifications. Here we investigate whether the blockade kinetics can be modulated by specifying the length of a poly(ethylene glycol) (PEG) spacer incorporated into the blocker. Single-channel electrophysiological experiments show that simple bis(trimethylammonium) compounds ( 1a- 3) both activate the AChR and block the open channel. The blockade kinetics are found to depend on spacer length: both the association and dissociation rate constants decrease with increasing spacer length. The decrease in the association rate constant can be quantitatively explained by the entropic cost of polymer confinement in the transmembrane lumen, while the decrease in the dissociation rate constant is consistent with weak, additive noncovalent interactions between the channel and the spacer. These results provide useful insights into the future design of kinetically tunable open-channel blockers for the AChR.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2008) studied this question. Polymer-based open-channel blockers with varying PEG spacer lengths was evaluated on Blockade kinetics (association and dissociation rate constants). Increasing the length of a poly(ethylene glycol) spacer in bis(trimethylammonium) compounds decreased both association and dissociation rate constants for acetylcholine receptor blockade.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: